scienceJan 31, 20221:11:34pending
PT283 – Greg McKee – Psychedelics for Nociplastic Pain
About this episode
In this episode of the podcast, Joe interviews Greg McKee: Chairman and CEO of Tryp Therapeutics, an early-stage biotech company researching the use of psilocybin derivatives to alleviate nociplastic pain like fibromyalgia.
Get every episode summarized
Each time Psychedelics Today publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Psychedelics Today
PT 660 - Josh Lipson & Roman Palitsky: Psychedelic Harms and the Post-Psychedeli...
Psychedelics Today
Aug 12, 20261:12:41pending
PT 659 - Megan Bowers & Mikayla Hellwich
Psychedelics Today
Aug 5, 20261:20:38pending
PT 658 - Mareesa Stertz – Sphinx Gate Beyond Burning Man: Psychedelic Healing Wi...
Psychedelics Today
Jul 31, 20261:15:19pending
PT 657 - Rachel Turetzky PhD & Douglas S. Wingate DTCM: The Eight-Circuit Model,...
Psychedelics Today
Jul 23, 20261:18:52pending